>
Switch to:

Indaptus Therapeutics EV-to-EBITDA

: (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Indaptus Therapeutics's enterprise value is $24.40 Mil. Indaptus Therapeutics does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Jun. 2021. Therefore, GuruFocus does not calculate Indaptus Therapeutics's EV-to-EBITDA at this moment.

The historical rank and industry rank for Indaptus Therapeutics's EV-to-EBITDA or its related term are showing as below:

NAS:INDP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -93.52   Med: 0   Max: 4.86
Current: -5.07

-93.52
4.86

During the past 0 years, the highest EV-to-EBITDA of Indaptus Therapeutics was 4.86. The lowest was -93.52. And the median was 0.00.

NAS:INDP's EV-to-EBITDA is ranked lower than
99.99% of the 37 Companies
in the Biotechnology industry.

( Industry Median: 17.53 vs. NAS:INDP: -5.07 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-10-19), Indaptus Therapeutics's stock price is $7.81. Indaptus Therapeutics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021. Therefore, GuruFocus does not calculate Indaptus Therapeutics's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Indaptus Therapeutics EV-to-EBITDA Historical Data

The historical data trend for Indaptus Therapeutics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indaptus Therapeutics Annual Data
Trend
EV-to-EBITDA

Indaptus Therapeutics Quarterly Data
Jun20 Mar21 Jun21
EV-to-EBITDA - - -

Competitive Comparison

For the Biotechnology subindustry, Indaptus Therapeutics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Indaptus Therapeutics EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Indaptus Therapeutics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Indaptus Therapeutics's EV-to-EBITDA falls into.



Indaptus Therapeutics EV-to-EBITDA Calculation

Indaptus Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=24.400/
=


Indaptus Therapeutics  (NAS:INDP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Indaptus Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.81/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Indaptus Therapeutics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Indaptus Therapeutics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Indaptus Therapeutics Business Description

Indaptus Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)